Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in <i>Pseudomonas aeruginosa</i> in Argentina

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Type of carbapenem</td><td class="align_center">Consumption level</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Ertapenem</td><td class="align_center">0.0067</td></tr><tr><td class="align_left">Imipenem</td><td class="align_center">0.024</td></tr><tr><td class="align_left">Meropenem</td><td class="align_center">0.033</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Consumption during 2018 was measured as defined daily dose by each 1000 inhabitant.<br/></div></td></tr></table>

<div>Level of global carbapenem consumption according to the drug type during 2018.</div>

Interdisciplinary Perspectives on Infectious Diseases

tab1

Table 1

Table 1: Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in <i>Pseudomonas aeruginosa</i> in Argentina 

Interdisciplinary Perspectives on Infectious Diseases

Association between Consumption of Fluoroquinolones and Carbapenems and Their Resistance Rates in Pseudomonas aeruginosa in Argentina

Table 1